Cargando…

Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers

Determination of oestrogen receptor alpha (ER) represents at present the most important predictive factor in breast cancers. Data of ours and of other authors suggest that promising predictive/prognostic factors may also include pS2, metallothionein (MT) and CD24. Present study aimed at determining...

Descripción completa

Detalles Bibliográficos
Autores principales:	Surowiak, P, Materna, V, Györffy, B, Matkowski, R, Wojnar, A, Maciejczyk, A, Paluchowski, P, Dzięgiel, P, Pudełko, M, Kornafel, J, Dietel, M, Kristiansen, G, Zabel, M, Lage, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360643/ https://www.ncbi.nlm.nih.gov/pubmed/16892043 http://dx.doi.org/10.1038/sj.bjc.6603254

Ejemplares similares

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance
por: Surowiak, Pawel, et al.
Publicado: (2005)

Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
por: Skliris, G P, et al.
Publicado: (2006)

PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer
por: Munkácsy, G, et al.
Publicado: (2010)

MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor
por: Halon, Agnieszka, et al.
Publicado: (2012)

Oestrogen receptor β and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment
por: Miller, W R, et al.
Publicado: (2006)

Expression of oestrogen receptor β and prognosis of colorectal cancer
por: Rudolph, A, et al.
Publicado: (2012)

Estrogen Receptor Alpha Expression in Ovarian Cancer Predicts Longer Overall Survival
por: Halon, Agnieszka, et al.
Publicado: (2011)

Oestrogen receptor-α contributes to the regulation of the hedgehog signalling pathway in ERα-positive gastric cancer
por: Kameda, C, et al.
Publicado: (2010)

Changes in subcellular localisation of MI-ER1α, a novel oestrogen receptor-α interacting protein, is associated with breast cancer progression
por: McCarthy, P L, et al.
Publicado: (2008)

Serum oestrogen receptor α and β bioactivity are independently associated with breast cancer: a proof of principle study
por: Widschwendter, M, et al.
Publicado: (2009)

Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer
por: West, N R, et al.
Publicado: (2013)

Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis
por: Rosin, G, et al.
Publicado: (2014)

NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation
por: Van Laere, S J, et al.
Publicado: (2007)

High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis
por: Weichert, W, et al.
Publicado: (2007)

17β-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer
por: Gunnarsson, C, et al.
Publicado: (2005)

Infrared spectroscopy with multivariate analysis to interrogate endometrial tissue: a novel and objective diagnostic approach
por: Taylor, S E, et al.
Publicado: (2011)

Role of metallothioneins in benign and malignant thyroid lesions
por: Pula, Bartosz, et al.
Publicado: (2012)

Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma
por: Rojo, Federico, et al.
Publicado: (2016)

Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
por: Kristiansen, G, et al.
Publicado: (2010)

Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer
por: Ohotski, J, et al.
Publicado: (2012)

Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion
por: Fry, Simon A, et al.
Publicado: (2016)

Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status
por: Fritzsche, F, et al.
Publicado: (2006)

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
por: Weichert, W, et al.
Publicado: (2008)

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
por: Kristiansen, G, et al.
Publicado: (2008)

Predicting 5-fluorouracil toxicity in colorectal cancer patients from peripheral blood cell telomere length: a multivariate analysis
por: Garg, M B, et al.
Publicado: (2012)

Rapid Paediatric Sequencing (RaPS): comprehensive real-life workflow for rapid diagnosis of critically ill children
por: Mestek-Boukhibar, Lamia, et al.
Publicado: (2018)

Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer
por: Jin, R, et al.
Publicado: (2000)

Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas
por: Palmieri, C, et al.
Publicado: (2012)

PS proton beam electronic counter
Publicado: (1980)

Expression of Metallothioneins in Cutaneous Squamous Cell Carcinoma and Actinic Keratosis
por: Zamirska, Aleksandra, et al.
Publicado: (2012)

A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma
por: Mihály, Z, et al.
Publicado: (2012)

Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer—what has gone wrong? A blueprint for the way forward in biomarker studies
por: Huber, F, et al.
Publicado: (2015)

Correlation Between PARP-1 Immunoreactivity and Cytomorphological Features of Parthanatos, a Specific Cellular Death in Breast Cancer Cells
por: Donizy, P., et al.
Publicado: (2013)

Comparision of the Cytotoxic Effects of Birch Bark Extract, Betulin and Betulinic Acid Towards Human Gastric Carcinoma and Pancreatic Carcinoma Drug-sensitive and Drug-Resistant Cell Lines
por: Drag, Marcin, et al.
Publicado: (2009)

Structure of mammalian metallothionein.
por: Kägi, J H, et al.
Publicado: (1984)

Metallothionein 3 Expression in Normal Skin and Malignant Skin Lesions
por: Pula, Bartosz, et al.
Publicado: (2014)

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study
por: Liu, Angela M, et al.
Publicado: (2012)

ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up
por: Halon, Agnieszka, et al.
Publicado: (2013)

Diagnostic potential of plasma biomarkers and exhaled volatile organic compounds in predicting the different stages of acute mesenteric ischaemia: protocol for a multicentre prospective observational study (TACTIC study)
por: Duivenvoorden, Annet A M, et al.
Publicado: (2023)

Sensitive and specific discrimination of pathogenic and nonpathogenic Escherichia coli using Raman spectroscopy—a comparison of two multivariate analysis techniques
por: Hamasha, Khozima, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4p661602onhkdgcitl4aq4qdfc